메뉴 건너뛰기




Volumn 54, Issue 5, 2011, Pages 1365-1378

Design, synthesis, and biological activity of potent and orally available g protein-coupled receptor 40 agonists

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 (BIPHENYL 2 YLMETHOXY)PHENYL]PROPANOIC ACID; 3 [4 (BIPHENYL 3 YLMETHOXY)PHENYL]PROPANOIC ACID; 3 [4 (BIPHENYL 4 YLMETHOXY)PHENYL]PROPANOIC ACID; 3 [4 [(2 PHENOXYBENZYL)OXY]PHENYL]PROPANOIC ACID; 3 [4 [(2' FLUOROBIPHENYL 3 YL)METHOXY]PHENYL]PROPANOIC ACID; 3 [4 [(2' METHOXYBIPHENYL 3 YL)METHOXY]PHENYL]PROPANOIC ACID; 3 [4 [(2' METHYLBIPHENYL 3 YL)METHOXY]PHENYL]PROPANOIC ACID; 3 [4 [(2',6' DIMETHYLBIPHENYL 3 YL)METHOXY] 2 FLUOROPHENYL]PROPANOIC ACID; 3 [4 [(2',6' DIMETHYLBIPHENYL 3 YL)METHOXY] 2 METHOXYPHENYL]PROPANOIC ACID; 3 [4 [(2',6' DIMETHYLBIPHENYL 3 YL)METHOXY] 2 METHYLPHENYL]PROPANOIC ACID; 3 [4 [(2',6' DIMETHYLBIPHENYL 3 YL)METHOXY] 2,6 DIFLUOROPHENYL]PROPANOIC ACID; 3 [4 [(2',6' DIMETHYLBIPHENYL 3 YL)METHOXY]PHENYL] 2 METHYLPROPANOIC ACID; 3 [4 [(2',6' DIMETHYLBIPHENYL 3 YL)METHOXY]PHENYL]BUTANOIC ACID; 3 [4 [(3 PHENOXYBENZYL)OXY]PHENYL]PROPANOIC ACID; 3 [4 [(3' METHYLBIPHENYL 3 YL)METHOXY]PHENYL]PROPANOIC ACID; 3 [4 [(4 PHENOXYBENZYL)OXY]PHENYL]PROPANOIC ACID; 3 [4 [(4' METHYLBIPHENYL 3 YL)METHOXY]PHENYL]PROPANOIC ACID; 3 [4 [[(2',6' DIMETHYLBIPHENYL 3 YL)METHYL]SULFANYL]PHENYL]PROPANOIC ACID; 3 [4 [[3 (2 METHYLPHENOXY)BENZYL]OXY]PHENYL]PROPANOIC ACID; 3 [4 [[3 (2 PHENYLETHOXY)BENZYL]OXY]PHENYL]PROPANOIC ACID; 3 [4 [[3 (2,6 DIMETHYLPHENOXY)BENZYL]OXY]PHENYL]PROPANOIC ACID; 3 [4 [[3 (3 METHYLPHENOXY)BENZYL]OXY]PHENYL]PROPANOIC ACID; 3 [4 [[3 (4 METHYLPHENOXY)BENZYL]OXY]PHENYL]PROPANOIC ACID; 3 [4 [[3 (BENZYLOXY)BENZYL]OXY]PHENYL]PROPANOIC ACID; ANTIDIABETIC AGENT; G PROTEIN COUPLED RECEPTOR 40 AGONIST; METHYL 3 [4 [(3 BROMOBENZYL)OXY]PHENYL]PROPANOIC ACID; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

EID: 79952261037     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101405t     Document Type: Article
Times cited : (87)

References (29)
  • 1
  • 4
    • 0032898667 scopus 로고    scopus 로고
    • Fatty acids, lipotoxicity and insulin secretion
    • DOI 10.1007/s001250051130
    • McGarry, J. D.; Dobbins, R. L. Fatty acids, lipotoxicity and insulin secretion Diabetologia 1999, 42, 128-138 (Pubitemid 29064233)
    • (1999) Diabetologia , vol.42 , Issue.2 , pp. 128-138
    • McGarry, J.D.1    Dobbins, R.L.2
  • 6
    • 0016866225 scopus 로고
    • Fatty acids, platelets, and microcirculatory obstruction
    • Spector, A. A.; Hoak, J. C. Fatty acids, platelets, and microcirculatory obstruction Science 1975, 190, 490-492
    • (1975) Science , vol.190 , pp. 490-492
    • Spector, A.A.1    Hoak, J.C.2
  • 7
    • 0029071517 scopus 로고
    • Metabolic coupling factors in pancreatic β-cell signal transduction
    • Newgard, C. B.; McGarry, J. D. Metabolic coupling factors in pancreatic β-cell signal transduction Annu. Rev. Biochem. 1995, 64, 689-719
    • (1995) Annu. Rev. Biochem. , vol.64 , pp. 689-719
    • Newgard, C.B.1    McGarry, J.D.2
  • 8
    • 11144246968 scopus 로고    scopus 로고
    • GPCR deorphanizations: The novel, the known and the unexpected transmitters
    • DOI 10.1016/j.tips.2004.11.005, PII S0165614704003116
    • Civelli, O. GPCR deorphanizations: the novel, the known and the unexpected transmitters Trends Pharmacol. Sci. 2005, 26, 15-19 (Pubitemid 40052705)
    • (2005) Trends in Pharmacological Sciences , vol.26 , Issue.1 , pp. 15-19
    • Civelli, O.1
  • 14
    • 34249682591 scopus 로고    scopus 로고
    • β-cell failure in diabetes and preservation by clinical treatment
    • DOI 10.1210/10.1210/er.2006-0038
    • Wajchenberg, B. L. beta-Cell failure in diabetes and preservation by clinical treatment Endocr. Rev. 2007, 28, 187-218 (Pubitemid 46984834)
    • (2007) Endocrine Reviews , vol.28 , Issue.2 , pp. 187-218
    • Wajchenberg, B.L.1
  • 16
    • 67649331670 scopus 로고    scopus 로고
    • Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): An emerging target for type 2 diabetes
    • For recent reviews, see
    • For recent reviews, see: Bharate, S. B.; Nemmani, K. VS.; Vishwakarma, R. A. Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes Exp. Opin. Ther. Pat. 2009, 19, 237-264
    • (2009) Exp. Opin. Ther. Pat. , vol.19 , pp. 237-264
    • Bharate, S.B.1    Nemmani, K.V.S.2    Vishwakarma, R.A.3
  • 20
    • 0030905211 scopus 로고    scopus 로고
    • One pot biaryl synthesis via in situ boronate formation
    • DOI 10.1016/S0040-4039(97)00767-3, PII S0040403997007673
    • Giroux, A.; Han, Y.; Prasit, P. One pot biaryl synthesis via in situ boronate formation Tetrahedron Lett. 1997, 38, 3841-3844 (Pubitemid 27264675)
    • (1997) Tetrahedron Letters , vol.38 , Issue.22 , pp. 3841-3844
    • Giroux, A.1    Han, Y.2    Prasit, P.3
  • 21
    • 0035945009 scopus 로고    scopus 로고
    • Odorless substitutes for foul-smelling thiols: Syntheses and applications
    • DOI 10.1016/S0040-4039(01)02024-X, PII S004040390102024X
    • Node, M.; Kumar, K.; Nishide, K.; Ohsugi, S.; Miyamoto, T. Odorless substitutes for foul-smelling thiols: syntheses and applications Tetrahedron Lett. 2001, 42, 9207-9210 (Pubitemid 33152886)
    • (2001) Tetrahedron Letters , vol.42 , Issue.52 , pp. 9207-9210
    • Node, M.1    Kumar, K.2    Nishide, K.3    Ohsugi, S.-I.4    Miyamoto, T.5
  • 22
    • 0025030095 scopus 로고
    • Hydrophobicity parameters determined by reversed-phase liquid chromatography. I. Relationship between capacity factors and octanol-water partition coefficients for monosubstituted pyrazines and the related pyridines
    • Yamagami, C.; Ogura, T.; Takao, N. Hydrophobicity parameters determined by reverse-phase liquid chromatography I. Relationship between capacity factors and octanol-water partition coefficients for monosubstituted pyrazines and the related pyridines J. Chromatogr. 1990, 514, 123-136 (Pubitemid 20256620)
    • (1990) Journal of Chromatography , vol.514 , Issue.2 , pp. 123-136
    • Yamagami, C.1    Ogura, T.2    Takao, N.3
  • 24
    • 84988073214 scopus 로고
    • Optimization of parameters for semiempirical methods II. Applications
    • Stewart, J. J. P. Optimization of parameters for semiempirical methods II. Applications J. Comput. Chem. 1989, 10, 209-220
    • (1989) J. Comput. Chem. , vol.10 , pp. 209-220
    • Stewart, J.J.P.1
  • 26
    • 0019743219 scopus 로고
    • A new genetically obese-hyperglycemic rat (Wistar fatty)
    • Ikeda, H.; Shino, A.; Matsuo, T.; Iwatsuka, H.; Suzuoki, Z. A new genetically obese-hyperglycemic rat (Wistar fatty) Diabetes 1981, 30, 1045-50
    • (1981) Diabetes , vol.30 , pp. 1045-50
    • Ikeda, H.1    Shino, A.2    Matsuo, T.3    Iwatsuka, H.4    Suzuoki, Z.5
  • 27
    • 0030971593 scopus 로고    scopus 로고
    • Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropyl- cyclohexanecarbonyl)-D-phenylalanine], on postprandial blood glucose excursion: Comparison with voglibose and glibenclamide
    • Ikenoue, T.; Okazaki, K.; Fujitani., S; Tsuchiya., Y; Akiyoshi, M.; Maki, T.; Kondo, N. Effect of a new hypoglycemic agent, A-4166 [(-)- N -(trans -4-isopropylcyclohexanecarbonyl)- d -phenylalanine], on postprandial blood glucose excursion: comparison with voglibose and glibenclamide Biol. Pharm. Bull. 1997, 20, 354-359 (Pubitemid 27212992)
    • (1997) Biological and Pharmaceutical Bulletin , vol.20 , Issue.4 , pp. 354-359
    • Ikenoue, T.1    Okazaki, K.2    Fujitani, S.3    Tsuchiya, Y.4    Akiyoshi, M.5    Maki, T.6    Kondo, N.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.